Fludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation

NCT01366612 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

53

Enrollment

OTHER

Sponsor class

Stopped Lack of Accrual

Conditions

Myeloid Malignancies
Acute Myelogenous Leukemia
Chronic Myelogenous Leukemia
Myeloproliferative Disorders
Myelodysplastic Syndrome

Interventions

DRUG: Fludarabine and Busulfan plus/minus Total Body Irradiation (low dose)
DRUG: Fludarabine and Busulfan + Low Dose Total Body Irradiation (LD TBI)

Sponsor

Hackensack Meridian Health